Emergence of Inflammatory Bowel Disease During Treatment With Secukinumab

被引:55
作者
Fobelo Lozano, Maria Jose [1 ]
Serrano Gimenez, Reyes [1 ]
Castro Fernandez, Manuel [2 ]
机构
[1] Valme Univ Hosp, Serv Pharm, Seville, Spain
[2] Valme Univ Hosp, Digest Med Serv, Seville, Spain
关键词
Secukinumab; IBD; adverse effects; clinical trials; epidemiology; pathology; CHRONIC MUCOCUTANEOUS CANDIDIASIS; CROHNS-DISEASE; CYTOKINES; MODERATE; SAFETY; IL-17;
D O I
10.1093/ecco-jcc/jjy063
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Secukinumab is an anti-IL 17A monoclonal antibody currently licensed for the treatment of plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. However, although inflammatory bowel disease is a disorder with related immune characteristics, secukinumab has not proved to be effective in these diseases. In fact, negative results in a clinical trial designed to assess the efficacy of secukinumab in patients with Crohn's disease have been published. On the other hand, the drug fact sheet states that secukinumab should be used with caution in patients with inflammatory bowel disease. Although the drug has shown to worsen these pathologies, there are no published data of cases in which the patient is first diagnosed with inflammatory bowel disease during secukinumab treatment. We present two cases of emergence of inflammatory bowel disease in patients with plaque psoriasis and ankylosing spondylitis, treated with secukinumab.
引用
收藏
页码:1131 / 1133
页数:3
相关论文
共 12 条
[1]  
Agencia Espanola de Medicamentos y Productos Sanitarios. CIMA (Centro de Informacion de Medicamentos), FICH TECN SEC
[2]  
Agencia Espanola de Medicamentos y Productos Sanitarios. CIMA (Centro de Informacion de Medicamentos), FICH TECN UST
[3]   Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis [J].
Baeten, Dominique ;
Sieper, Joachim ;
Braun, Juergen ;
Baraliakos, Xenofon ;
Dougados, Maxime ;
Emery, Paul ;
Deodhar, Atul ;
Porter, Brian ;
Martin, Ruvie ;
Andersson, Mats ;
Mpofu, Shephard ;
Richards, Hanno B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (26) :2534-2548
[4]   Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease [J].
Dige, Anders ;
Stoy, Sidsel ;
Rasmussen, Tue K. ;
Kelsen, Jens ;
Hvas, Christian L. ;
Sandahl, Thomas D. ;
Dahlerup, Jens F. ;
Deleuran, Bent ;
Agnholt, Jorgen .
JOURNAL OF CROHNS & COLITIS, 2013, 7 (03) :248-255
[5]   Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases [J].
Fragoulis, George E. ;
Siebert, Stefan ;
McInnes, Iain B. .
ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 :337-353
[6]   Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial [J].
Hueber, Wolfgang ;
Sands, Bruce E. ;
Lewitzky, Steve ;
Vandemeulebroecke, Marc ;
Reinisch, Walter ;
Higgins, Peter D. R. ;
Wehkamp, Jan ;
Feagan, Brian G. ;
Yao, Michael D. ;
Karczewski, Marek ;
Karczewski, Jacek ;
Pezous, Nicole ;
Bek, Stephan ;
Bruin, Gerard ;
Mellgard, Bjoern ;
Berger, Claudia ;
Londei, Marco ;
Bertolino, Arthur P. ;
Tougas, Gervais ;
Travis, Simon P. L. .
GUT, 2012, 61 (12) :1693-1700
[7]   Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis [J].
Liu, Luyan ;
Okada, Satoshi ;
Kong, Xiao-Fei ;
Kreins, Alexandra Y. ;
Cypowyj, Sophie ;
Abhyankar, Avinash ;
Toubiana, Julie ;
Itan, Yuval ;
Audry, Magali ;
Nitschke, Patrick ;
Masson, Cecile ;
Toth, Beata ;
Flatot, Jerome ;
Migaud, Melanie ;
Chrabieh, Maya ;
Kochetkov, Tatiana ;
Bolze, Alexandre ;
Borghesi, Alessandro ;
Toulon, Antoine ;
Hiller, Julia ;
Eyerich, Stefanie ;
Eyerich, Kilian ;
Gulacsy, Vera ;
Chernyshova, Ludmyla ;
Chernyshov, Viktor ;
Bondarenko, Anastasia ;
Cortes Grimaldo, Rosa Maria ;
Blancas-Galicia, Lizbeth ;
Madrigal Beas, Ileana Maria ;
Roesler, Joachim ;
Magdorf, Klaus ;
Engelhard, Dan ;
Thumerelle, Caroline ;
Burgel, Pierre-Regis ;
Hoernes, Miriam ;
Drexel, Barbara ;
Seger, Reinhard ;
Kusuma, Theresia ;
Jansson, Annette F. ;
Sawalle-Belohradsky, Julie ;
Belohradsky, Bernd ;
Jouanguy, Emmanuelle ;
Bustamante, Jacinta ;
Bue, Melanie ;
Karin, Nathan ;
Wildbaum, Gizi ;
Bodemer, Christine ;
Lortholary, Olivier ;
Fischer, Alain ;
Blanche, Stephane .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (08) :1635-1648
[8]   Yeasts: Neglected Pathogens [J].
Poulain, Daniel ;
Sendid, Boualem ;
Standaert-Vitse, Annie ;
Fradin, Chantal ;
Jouault, Thierry ;
Jawhara, Samir ;
Colombel, Jean-Frederic .
DIGESTIVE DISEASES, 2009, 27 :104-110
[9]   Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I [J].
Puel, Anne ;
Doeffinger, Rainer ;
Natividad, Angels ;
Chrabieh, Maya ;
Barcenas-Morales, Gabriela ;
Picard, Capucine ;
Cobat, Aurelie ;
Ouachee-Chardin, Marie ;
Toulon, Antoine ;
Bustamante, Jacinta ;
Al-Muhsen, Saleh ;
Al-Owain, Mohammed ;
Arkwright, Peter D. ;
Costigan, Colm ;
McConnell, Vivienne ;
Cant, Andrew J. ;
Abinun, Mario ;
Polak, Michel ;
Bougneres, Pierre-Francois ;
Kumararatne, Dinakantha ;
Marodi, Laszlo ;
Nahum, Amit ;
Roifman, Chaim ;
Blanche, Stephane ;
Fischer, Alain ;
Bodemer, Christine ;
Abel, Laurent ;
Lilic, Desa ;
Casanova, Jean-Laurent .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (02) :291-297
[10]   Proinflammatory cytokines underlying the inflammation of Crohn's disease [J].
Strober, Warren ;
Zhang, Fuping ;
Kitani, Atsushi ;
Fuss, Ivan ;
Fichtner-Feigl, Stefan .
CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (04) :310-317